Regenstrief researcher co-leading $16M Alzheimer’s research program
Kosali Simon, an Indiana University and Regenstrief Institute researcher, will study the treatment and outcomes of patients with Alzheimer’s and related dementias.
Read MoreKosali Simon, an Indiana University and Regenstrief Institute researcher, will study the treatment and outcomes of patients with Alzheimer’s and related dementias.
Read MoreThe national study co-authored by researchers at Indianapolis-based Regenstrief Institute and other agencies across the country was designed to gauge the effectiveness and durability of the third and fourth doses of COVID vaccine boosters.
Read MoreThe partners will utilize the Indiana Network for Patient Care, which was created by Regenstrief and is managed by the Indiana Health Information Exchange, to mine data from electronic health records.
The not-for-profit and its health research are a testament to the idea that all innovation is related—even when the connection appears tenuous at first glance.
Protocols for whom and how often to test those re-entering the workforce will be important.